Alydia Health

Alydia Health specializes in intrauterine haemostatic suction catheters. These devices are specifically designed for uterine evacuation procedures, such as manual vacuum aspiration and dilation and curettage (D&C). Their primary function is to provide controlled suction and haemostasis during surgical interventions to remove uterine contents.

Alydia Health is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework, as its devices are authorised under US medical device regulations.

Alydia Health’s devices are listed in the FDA’s regulatory databases, specifically through the 510(k) premarket notification process and UDI (Unique Device Identification) compliance. These registries ensure traceability and compliance with US medical device regulations.

Alydia Health’s devices fall under Class II classification in the US. This classification is determined by the FDA based on the level of risk associated with the device’s intended use. Class II devices require special controls in addition to general controls to ensure safety and effectiveness.